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ALS-associated SOD1 mutations activate cellular Nox activity. (A) Rate of NADPH-dependent O2•– production by total endomembranes iso-
lated from the brain, spinal cord, and liver of nontransgenic or transgenic mice overexpressing SOD1WT or SOD1G93A (mean ± SEM; n = 3 per 
group). (B) DHE fluorescent detection of O2•– in lumbar spinal cord sections from nontransgenic and transgenic mice overexpressing SOD1WT or 
SOD1G93A. DAPI staining shows cell nuclei in each section. (C) Rate of NADPH-dependent O2•– production in total endomembranes isolated from 
SH-SY (neuronal) or MO59J (glial) cells at 48 hours following infection with adenoviral vectors expressing LacZ, SOD1WT, SOD1L8Q, or SOD1G93A. 
(D) Cell death was quantified in SH-SY and MO59J cells using trypan-blue exclusion at 72 hours after infection with the indicated adenoviral 
vectors. (E) Using conditions specified in C and D, the rate of NADPH-dependent O2•– production and cell death was assessed in the presence 
or absence of the Nox inhibitor apocynin (100 μM). Values are mean ± SEM (n = 6 per group). (F) Assessment of GTP-bound Rac1 (activated 
form) in spinal cord lysates from 2 nontransgenic or 3 SOD1G93A transgenic mice (120 days old) and from MO59J cells overexpressing WT or 
mutant SOD1 proteins (at 36 hours after adenoviral infection). The 2 left lanes are controls for the Rac activation assay, in which nontransgenic 
spinal cord lysates were preincubated with the indicated non-hydrolysable guanine nucleotide analogs.
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Rac1 binds to SOD1 in a redox-dependent manner. (A) Rac1 IP from heart, kidney, liver, and/or brain tissue of SOD1+/+ or SOD1–/– mice followed 
by Western blotting (WB) for SOD1 and Rac1. (B) In vitro IP of purified His-tagged Rac1 and Cdc42 in the presence of purified bovine SOD1 
followed by Western blot for SOD1, Rac1, and Cdc42. The His-tagged GTPases were preloaded with the indicated nucleotide analogs prior to 
incubation with SOD1. (C) In vitro IP of purified His-tagged Rac1 in the presence of purified native, demetalated, or remetalated bovine SOD1 
followed by Western blot for SOD1 and Rac1. The His-tagged Rac1 was preloaded with the indicated nucleotide analogs prior to incubation with 
SOD1. Additionally, untreated His-tagged Rac1 and 300 μM DTT prereduced His-tagged Rac1 were used for in vitro pulldown assays with each 
of the 3 forms of SOD1. (D) His-tagged Rac1 was prereduced (300 μM DTT), loaded with GTPγS, and treated with the indicated concentrations 
of H2O2 before performing pulldown assays with SOD1. (E) The indicated concentrations of DTT were added to the 300 pM H2O2-treated His-
tagged Rac1 sample in D, and pulldown assays were performed with SOD1. (F) Schematic of GST-Rac1 deletion mutants used to define the 
SOD1 binding domain and in vitro IP of various GST-tagged Rac1 deletion mutants in the presence of purified bovine SOD1. GST-Rac1 fusion 
construct numbers above correspond with lane numbers below. Top lanes are Western blot for SOD1 following IP of GST; bottom lanes are 
Coomassie-stained gel of the purified fusion peptides used for IP.
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SOD1 regulates Rac1/Nox2 activation, and this function is dysregu-
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Figure 3
SOD1 activates Rac1 and Nox2, a function dysregulated in certain SOD1 ALS mutants. (A and B) Rac1 GTPase assays were performed in the pres-
ence or absence of purified (A) bovine SOD1 or (B) E. coli MnSOD and/or p29-GAP. His-tagged Rac1 was preloaded with γP32-GTP, and aliquots of 
the reaction were analyzed at various time points by TLC for GTP hydrolysis by assessing percent 32Pi released from Rac1. (C) GTPase assay for 
Rac1 and Cdc42 in the presence or absence of bovine SOD1 and/or p29-GAP. (D) Rac1 GTPase assay in the presence or absence of bovine SOD1 
and/or X/XO (100 mU; final concentration 100 μM). (E) Pulldown assays of GTPγS-loaded His-tagged Rac1 in the presence of bovine SOD1 with or 
without 15-minute exposure to X/XO-derived ROS. Data are representative of at least 3 independent experiments. (F) Endosomes were isolated from 
PMDFs using Iodixanol density gradient fractionation, and fractions were characterized by Western blot for Nox2gp91phox, Rac1, SOD1, and EEA1. (G) 
Lucigenin assays were used to assess the rate of NADPH-dependent O2•− production in fraction 10 vesicles from Nox2 WT and KO PMDFs in the 
presence or absence of 2.5 μM bovine SOD1 and/or 10 μM DPI, a general Nox inhibitor (n = 6). (H) Vesicular fractions from PMEFs heterozygous for 
a gene disruption of mouse SOD1 were assessed for NADPH-dependent O2•− production in the presence or absence of exogenously added 2.5 μM 
bovine SOD1 or 2.5 μM E. coli MnSOD (n = 3). (I) Coomassie-stained SDS-PAGE of purified bacterially expressed human SOD1 proteins. Bovine 
SOD1 was used as a reference control and migrates faster than human SOD1 (12). The Cu/Zn content of each SOD1 protein is shown. SOD activity 
gel of the bacterial purified SOD1 proteins is shown at bottom. (J) In vitro IP of purified prereduced His-tagged Rac1-GTPγS in the presence of the 
indicated human SOD1 proteins. Rac1/SOD1 complexes were then divided into 2 parts; 1 half was treated with X/XO-derived ROS for 15 minutes at 
room temperature prior to IP of the His-tag. Following IP, Western blots for SOD1 and Rac1 were performed. Long and short exposures of the SOD1 
blot are shown to demonstrate enhanced binding of each of the mutant forms of SOD1 to Rac1. (K) Rac1 GTPase assays were performed using 
native bovine SOD1 or the indicated bacterially expressed purified human SOD1 proteins. The molar ratio of Rac1/SOD1 is indicated. (L) Time course 
of NADPH-dependent O2•− generation by isolated PMEF endosomes in the presence or absence of 1 μM human SOD1WT or SOD1L8Q.
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Treatment with the Nox inhibitor apocynin increases lifespan and slows disease progression in mice hemizygous for the SOD1G93A transgene. 
(A) Kaplan-Meier survival curve for mice treated with indicated doses of apocynin in their water beginning at 14 days of age. n is shown along 
with median survival time (arrowhead) for each group. Survival differences were significant in all between-group comparisons (log-rank test). (B) 
Age of disease onset, as determined by a 10% weight loss from peak body weight, for the various doses of apocynin. (C) Dose affect of apocynin 
treatment on survival index, measured as time from disease onset (as determined by weight loss) until clinical death. (D) Rate of NADPH-depen-
dent O2•– production in total endomembranes isolated from lumbar spinal cords of end-stage SOD1G93A transgenic mice (~120 days of age) that 
were either untreated or treated with apocynin (300 mg/kg) in the drinking water for 5 days prior to harvesting spinal cords (n = 5 per group). (E) 
DHE fluorescence was assessed in lumbar spinal cord sections from 2 mice evaluated in D. (F) Survival data of male and female mice at the 
indicated apocynin dose. Mice treated for eye infections with antibiotics are marked as squares; those unsuccessfully treated that died from eye 
infections are marked by “X” within the square. Circles denote animals that never contracted eye infection. n and mean survival time is indicated 
for each group. Data in B–D are mean ± SEM.
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Redox-sensor model for SOD1-mediated regulation of Nox2 ROS pro-
duction through Rac. Under reducing conditions SOD1 is bound to 
Rac-GTP and stabilizes Rac activation by inhibiting intrinsic and GAP-
mediated GTP hydrolysis. Increased Rac-GTP levels lead to activation 
of Nox2 and production of O2•−. O2•− generated by the Nox2 complex 
is converted to H2O2 by SOD1 or through spontaneous dismutation. 
As the local concentration of H2O2 rises, oxidation of Rac leads to 
the dissociation of SOD1. With SOD1 no longer bound to Rac-GTP, 
hydrolysis to Rac-GDP occurs more quickly, leading to inactivation of 
the Nox2 complex. SOD1 can then recycle to repeat the process as 
Rac/Nox2 is reactivated. Through this mechanism, we propose that 
SOD1 can sense the local concentration of ROS at sites of Rac/Nox2 
complex activation and control the activity of the complex. In certain 
ALS mutants of SOD1, redox-dependent dissociation of SOD1 from 
Rac1 is impaired, leading to sustained activation of Rac1-GTP and 
higher levels of Nox2 activation.
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Lucigenin chemiluminescence assay  
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